If you're looking at private health insurers on the ASX, you might want to take note of what Health Minister Mark Butler has to say...
Good forecasting economists maintain inflation’s on track to keep falling, which takes pressure off rate rises. But there are two sides of the coin here.
If you paid extra for “high performance” fuel at certain Mobil sites in Queensland, the Federal Court says you weren’t getting what the signage promised.
The global financial body, the IMF, says the housing policy of the Albanese government will primarily serve to drive house prices too high!
Australian airwaves have already played host to AI spinning the wheels of steel but now the regulator has stepped in.
Tax breaks? Incentives? Road use charges? The government is spending billions on getting Aussies into EVs. But which is the most effective use of that...
JB Hi-Fi’s latest numbers show the retailer is holding its own, even with interest rates biting and shoppers feeling the squeeze.
Markets are volatile, tech stocks have been sold off, and banks and miners have led recent gains. And yet, the ASX200 continues to flirt with...
Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing…
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.